An organ transplant drug from Bristol-Myers Squibb Co called as belatacept has received backing from an expert panel of the Food and Drug Administration.
An organ transplant drug from Bristol-Myers Squibb Co called as belatacept has received backing from an expert panel of the Food and Drug Administration. The panel voted 13-5 in favor of the drug, which is given to organ transplant recipients to prevent rejection.
Bristol's drugs is thought to be better than older drugs, which caused headaches, nausea and liver toxicity. In a study, patients on belatacept had improved kidney function and lower blood pressure, which are key indicators of survival.
About Transplantation
Since the early times, the novel idea of transplanting tissues and other body parts from one organism to the other has captured the imagination of successive generations.
Since the early times, the novel idea of transplanting tissues and other body parts from one organism to the other has captured the imagination of successive generations.
Source-Medindia
RAS
Liver Transplantation - Facts, Contraindications, Procedure, Follow up, Complications & Prognosis
Liver transplantation is a surgical option for the treatment of liver failure where the diseased liver is replaced with a healthy one.
Liver transplantation is a surgical option for the treatment of liver failure where the diseased liver is replaced with a healthy one.
